Comparison Between Clinician- and Patient-Reporting of Baseline (BL) and Post-BL Symptomatic Toxicities in Cancer Cooperative Group Clinical Trials (NCCTG N0591 [Alliance])
      Google Scholar   
Citation:
J Clin Oncol vol 33 (suppl) abstr 9520
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
2190   3108  
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA025224  
Corr. Author:
 
Authors:
               
Networks:
LAPS-MN026, LAPS-NC007, LAPS-NY016   
Study
NCCTG-N0591
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: